A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
MEI Pharma, Inc.
MEI Pharma, Inc.
Novartis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Incyte Corporation
Roswell Park Cancer Institute
Adicet Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Aprea Therapeutics
Janssen Research & Development, LLC
Oncternal Therapeutics, Inc
University of Wisconsin, Madison
Genmab
Academic and Community Cancer Research United
Taiho Oncology, Inc.
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
Amgen
ADC Therapeutics S.A.
Prelude Therapeutics
Stanford University
University of Alabama at Birmingham
University of Nebraska
Polish Lymphoma Research Group
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Asana BioSciences
MEI Pharma, Inc.
AbbVie
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
TG Therapeutics, Inc.
Eden BioCell Ltd.
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
Swiss Cancer Institute
Brown University
The First Affiliated Hospital with Nanjing Medical University
ADC Therapeutics S.A.
Weill Medical College of Cornell University
University of Washington
M.D. Anderson Cancer Center
Takeda
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Gilead Sciences